R-Biopharmnews II/2011
RIDASCREEN® Gliadin competitive RIDASCREEN®FAST Lysozym RIDASCREEN® Nitrofuran (SEM) – Un nouveau kit ELISA pour la détection quantitative des antibiotiques de la famille des nitrofurans RIDASCREEN®...
View ArticleR-Biopharmnews I/2012
Le kit RIDASCREEN® Gliadin validé comme méthode officielle « AOAC Official First Action » Extraction de la gliadine/du gluten et de la caséine Cocktail (breveté) (art. non. R7006 / R7016) RIDA®...
View ArticleR-Biopharmnews I/2012
Le kit RIDASCREEN® Gliadin validé comme méthode officielle « AOAC Official First Action » Extraction de la gliadine/du gluten et de la caséine Cocktail (breveté) (art. non. R7006 / R7016) RIDA®...
View ArticleR-Biopharmnews II/2012
RIDASCREEN® Tetracyclin(R3505)Nouveau! Le Kit RIDASCREEN® Campylobacter (R4204) est disponible depuis le mois de mai. RIDASCREEN® Gliadin competitive (R7021) – Analyse d’échantillons d’aliments...
View ArticleR-Biopharmnews II/2012
RIDASCREEN® Tetracyclin(R3505)Nouveau! Le Kit RIDASCREEN® Campylobacter (R4204) est disponible depuis le mois de mai. RIDASCREEN® Gliadin competitive (R7021) – Analyse d’échantillons d’aliments...
View ArticleNew rapid test format of RIDA®QUICK Norovirus available
Progress in reliability at simplified work flow The RIDA®QUICK Norovirus Test is a qualitative immunochromatographic lateral flow rapid test for determining Genogroup 1 (GG I) and Genogroup 2 (GG II)...
View ArticleR-Biopharmnews III/2012
« Étiquetage obligatoire des allergènes contenus dans le vin à partir de juillet 2012 » « EnzytecTM Color tartaric acid (E3100) » « RIDASCREEN® FAST Macadamia (R6852) » « RIDASCREEN®Gliadin...
View ArticleR-Biopharmnews III/2012
« Étiquetage obligatoire des allergènes contenus dans le vin à partir de juillet 2012 » « EnzytecTM Color tartaric acid (E3100) » « RIDASCREEN® FAST Macadamia (R6852) » « RIDASCREEN®Gliadin...
View ArticleR-Biopharm news Clinical Diagnostics June 2013
RIDA®QUICK Clostridium difficile GDH RIDA®GENE Bordetella and RIDASCREEN® Bordetella PT IgG & IgA RIDA®GENE Clostridium difficile and RIDA® GENE Clostridium difficile LC2.0 RIDA®GENE Entamoeba...
View ArticleRIDA qLine® Allergy
The Next Generation of Allergy In-Vitro-Diagnostics R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a...
View Article3rd time in a row: Deloitte Sustained Excellence Award
Sustainable excellence in longterm and profitable growth awarded After awards in 2010 and 2013, R-Biopharm AG has won the Deloitte Sustained Excellence Award for the third time in a row this year....
View ArticleDrug Monitoring of Infliximab Biosimilars RemsimaTM and Inflectra®
Ann Gils and her colleagues from KU Leuven evaluated if the biosimilars RemsimaTM and Inflectra® were equally well quantified as Remicade® (Infliximab, IFX) in their clinically validated infliximab...
View ArticleDrug Monitoring reduces Infliximab treatment costs
Study about first randomized, controlled testing shows that clinical treatment decisions based on therapeutic drug monitoring (TDM) is superior to dose-intensification strategy. One common way of...
View ArticleCalprotectin predicts relaps after stopping TNFα treatment
Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn. The...
View ArticleInflammatory Bowel Disease – TNFalpha Blocker Treatment and Calprotectin
Chronic inflammatory bowel disease (IBD) is characterized by recurring and often ongoing flares. The most common forms of IBD are Crohns disease and Ulcerative colitis. Stopping the inflammatory cycle...
View ArticleClik here to view.
Les 20 ans de R-Biopharm News !
Nous sommes heureux de vous présenter la 20ème édition de R-Biopharm News – Diagnostique agro-alimentaire. Vous trouverez de nombreux articles susceptibles de vous intéresser : Les 20 ans de...
View ArticleClik here to view.
RIDA®GENE MRSA – Excellent quality assessment result
Excellent results of the RIDA®GENE MRSA real-time PCR assay in the external quality assessment program of Instand e.V. Repeatedly, the R-Biopharm AG participated successfully in the INSTAND external...
View ArticleRIDA qLine® Allergy Quality Assessment – Register now!
R-Biopharm starts RIDA qLine® Allergy External Quality Assessment. This new tool will help to ensure the quality of the testing procedures in laboratories using RIDA qLine® Allergy and the laboratories...
View ArticleDetection of Legionella with RIDASCREEN® Legionella
The new assay RIDASCREEN ® Legionella of R-Biopharm closes the gap in test portfolio for the detection of life-threatening infectious diseases. Fast and reliable detection of Legionella The ELISA...
View ArticleClik here to view.
Helicobacter pylori & its resistance against clarithromycin – detect it...
RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human tissue...
View Article